138 related articles for article (PubMed ID: 16443507)
1. Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development.
Baird DD; Kesner JS; Dunson DB
J Soc Gynecol Investig; 2006 Feb; 13(2):130-5. PubMed ID: 16443507
[TBL] [Abstract][Full Text] [Related]
2. Self-reported heavy bleeding associated with uterine leiomyomata.
Wegienka G; Baird DD; Hertz-Picciotto I; Harlow SD; Steege JF; Hill MC; Schectman JM; Hartmann KE
Obstet Gynecol; 2003 Mar; 101(3):431-7. PubMed ID: 12636944
[TBL] [Abstract][Full Text] [Related]
3. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
Wise LA; Palmer JR; Stewart EA; Rosenberg L
Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025
[TBL] [Abstract][Full Text] [Related]
4. Potential risk factors associated with subtypes of uterine leiomyomata.
Dragomir AD; Schroeder JC; Connolly A; Kupper LL; Hill MC; Olshan AF; Baird DD
Reprod Sci; 2010 Nov; 17(11):1029-35. PubMed ID: 20693498
[TBL] [Abstract][Full Text] [Related]
5. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.
Wise LA; Palmer JR; Harlow BL; Spiegelman D; Stewart EA; Adams-Campbell LL; Rosenberg L
Am J Epidemiol; 2004 Jan; 159(2):113-23. PubMed ID: 14718211
[TBL] [Abstract][Full Text] [Related]
6. Natural history of uterine polyps and leiomyomata.
DeWaay DJ; Syrop CH; Nygaard IE; Davis WA; Van Voorhis BJ
Obstet Gynecol; 2002 Jul; 100(1):3-7. PubMed ID: 12100797
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
[TBL] [Abstract][Full Text] [Related]
8. Reproductive characteristics and risk of uterine leiomyomata.
Terry KL; De Vivo I; Hankinson SE; Missmer SA
Fertil Steril; 2010 Dec; 94(7):2703-7. PubMed ID: 20627243
[TBL] [Abstract][Full Text] [Related]
9. A prospective ultrasound study of cigarette smoking and uterine leiomyomata incidence and growth.
Wesselink AK; Wegienka G; Coleman CM; Geller RJ; Harmon QE; Upson K; Lovett SM; Claus Henn B; Marsh EE; Noel NL; Baird DD; Wise LA
Am J Obstet Gynecol; 2023 Aug; 229(2):151.e1-151.e8. PubMed ID: 37148957
[TBL] [Abstract][Full Text] [Related]
10. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M
Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
[TBL] [Abstract][Full Text] [Related]
11. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.
Wise LA; Palmer JR; Spiegelman D; Harlow BL; Stewart EA; Adams-Campbell LL; Rosenberg L
Epidemiology; 2005 May; 16(3):346-54. PubMed ID: 15824551
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study.
Marino JL; Eskenazi B; Warner M; Samuels S; Vercellini P; Gavoni N; Olive D
Hum Reprod; 2004 Oct; 19(10):2350-5. PubMed ID: 15242998
[TBL] [Abstract][Full Text] [Related]
13. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
Baird DD; Dunson DB; Hill MC; Cousins D; Schectman JM
Am J Obstet Gynecol; 2003 Jan; 188(1):100-7. PubMed ID: 12548202
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
[TBL] [Abstract][Full Text] [Related]
15. Vitamin d and the risk of uterine fibroids.
Baird DD; Hill MC; Schectman JM; Hollis BW
Epidemiology; 2013 May; 24(3):447-53. PubMed ID: 23493030
[TBL] [Abstract][Full Text] [Related]
16. Association of physical activity with development of uterine leiomyoma.
Baird DD; Dunson DB; Hill MC; Cousins D; Schectman JM
Am J Epidemiol; 2007 Jan; 165(2):157-63. PubMed ID: 17090618
[TBL] [Abstract][Full Text] [Related]
17. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
18. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
19. Neonatal outcomes in women with sonographically identified uterine leiomyomata.
Lai J; Caughey AB; Qidwai GI; Jacoby AF
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):710-3. PubMed ID: 22409539
[TBL] [Abstract][Full Text] [Related]
20. Dietary Fat Intake and Risk of Uterine Leiomyomata: A Prospective Ultrasound Study.
Brasky TM; Bethea TN; Wesselink AK; Wegienka GR; Baird DD; Wise LA
Am J Epidemiol; 2020 Dec; 189(12):1538-1546. PubMed ID: 32556077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
